It is increasingly recognized that symptoms of heart disease are different for men and women. But it appears we are often slower to recognize heart disease in women, resulting in important distinctions in early treatment and outcomes. What are these differences, and how can we, as providers, help narrow this gender gap? Host Dr. Janet Wright welcomes Dr. Rita Redberg, professor of clinical medicine at the University of California, San Francisco, School of Medicine (UCSF), and director of women's cardiovascular services at the UCSF National Center for Excellence in Women's Health, for an important conversation about where can we do a better job of encouraging women to be aware of cardiac concerns specific to women? Dr. Redberg also shares her approach to evaluating female patients with symptoms that are suggestive but not definitive.
Women and Heart Disease: Closing the Outcomes Gap
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
It is increasingly recognized that symptoms of heart disease are different for men and women. But it appears we are often slower to recognize heart disease in women, resulting in important distinctions in early treatment and outcomes. What are these differences, and how can we, as providers, help narrow this gender gap? Host Dr. Janet Wright welcomes Dr. Rita Redberg, professor of clinical medicine at the University of California, San Francisco, School of Medicine (UCSF), and director of women's cardiovascular services at the UCSF National Center for Excellence in Women's Health, for an important conversation about where can we do a better job of encouraging women to be aware of cardiac concerns specific to women? Dr. Redberg also shares her approach to evaluating female patients with symptoms that are suggestive but not definitive.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?